Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1991-03-19 to 1991-05-06
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP and guideline compliant study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1991
Report date:
1991

Materials and methods

Objective of study:
distribution
excretion
Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 417 (Toxicokinetics)
Deviations:
no
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Tris(2-hydroxyethyl)methylammonium methyl sulphate
EC Number:
249-655-6
EC Name:
Tris(2-hydroxyethyl)methylammonium methyl sulphate
Cas Number:
29463-06-7
Molecular formula:
C7H18NO3.CH3O4S
IUPAC Name:
1,5-dihydroxy-3-(2-hydroxyethyl)pentan-3-aminium methyl sulfate
Details on test material:
- Name of test material 1: N-Tris-(2-hydroxyethyl)-methylammonium-methosulfate- Substance type: organic- Physical state: yellow solution in water- Analytical purity: about 98 %- Lot/batch No.: 1072321- Storage condition of test material: at room temperature in the dark- Name of test material 2: N-Tris-(2-hydroxyethyl)-14C-methylammonium-iodide- Substance type: organic- Physical state: yellow solution in oil- Lot/batch No.: CFO 6020- Radiochemical purity (if radiolabelling): > 98 %- Specific activity (if radiolabelling): 7.3 mCi/mmole- Storage condition of test material: stored at -20 °C in the dark
Radiolabelling:
yes
Remarks:
(N-Tris-(2-hydroxyethyl)-14C-methylammonium-iodide is almost identical to the test substance and was therefore used in a mixture application with the test substance.)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS- Source: Charles River Wega Ltd., Sulzfeld, Germany- Age at study initiation: 8 - 10 weeks- Weight at study initiation: 200 - 300 g- Fasting period before study: no- Housing: individually- Individual metabolism cages: yes- Diet: ad libitum, Altromin diet- Water: ad libitum, tap water- Acclimation period: yesENVIRONMENTAL CONDITIONS- Temperature (°C): 21±2- Humidity (%): 55±15- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: solution in 0.9 % NaCl
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:The test substance N-Tris-(2-hydroxyethyl)-14C-methylammonium-iodide was prepared as a solution in 0.9 % NaCl. In the main study one group was given a dose calculated to yield final concentration of about 1 mg of undiluted N-Tris-(2-hydroxyethyl)-14C-methylammonium-iodide per kg body weight. The doses actually achieved were about 0.9 mg/kg body weight for the female and about 0.6 mg/kg body weight for the male animals. The other group received amounts of radioactivity (N-Tris-(2-hydroxyethyl)-14C-methylammonium-iodide diluted 1:5 with the non radioactive test substance) expected to result in final doses of about 100 mg/kg body weight. The doses achieved had means of about 100 mg/kg body weight for the female animals and about 97 mg/kg body weight for the males.
Duration and frequency of treatment / exposure:
Single oral dose was administered to the rats. They were kept in metabolism cages 24 hours before dosing and 72 hours afterwards.
Doses / concentrations
Remarks:
Doses / Concentrations:100 mg/kg bw
No. of animals per sex per dose / concentration:
4
Control animals:
no
Positive control reference chemical:
no
Details on dosing and sampling:
PHARMACOKINETIC STUDY (Absorption, distribution, excretion)- Tissues and body fluids sampled: urine, faeces, blood, cage washes, expired CO2 of two animals- Time and frequency of sampling: 8, 24, 48 and 72 hours after administration- Other: The following organs were collected after sacrifice: brain, heart, lung, liver, kidney, urinary bladder and gastrointestinal tract

Results and discussion

Preliminary studies:
After a single intravenous administration of radioactive N-Tris(2-hydroxyethyl)-methylammonium-iodide to two female rats and one male the total recovery of radioactive material in urine was 96.1±1.1 %. The excretion of the radioactivity with the urine was fast. During the first 24h about 90 % of the administered radioactivity was excreted with the urine. The total recovery of radioactive material in feces was low, about 1.31±0.12 %. Most of this was excreted in the first 48h. In all organs examined (heart, lung, liver kidneys, urinary bladder, gastro-intestinal tract) the amount of radioactivity detected was very low, in total about 0.27 % of the administered dose. The organs with the highest amount of radioactive material were the liver (about 0.1 %) followed by the gastro-intestinal tract (about 0.07 %) and the blood (about 0.05 %). The radiochemical dose found in the expired air was low (about 0.6 %). The overall recovery, without the residual carcasses was about 99.4 + 0.60 % of the radiochemical dose. The preliminary study supports the hypothesis that the biliary excretion of the test substance is of no importance.
Main ADME resultsopen allclose all
Type:
distribution
Results:
relevant recovery levels only seen in liver, gastrointestinal tract and blood
Type:
excretion
Results:
mainly in urine and faeces

Toxicokinetic / pharmacokinetic studies

Details on distribution in tissues:
In all organs examined (heart, lung, liver kidneys, urinary bladder, gastro-intestinal tract) the amount of radioactivity detected was very low, in total about 0.39 % of the administered dose. Only the liver (female: 0.07 %, male: 0.17 %), the gastro-intestinal tract (female: 0.13 %, male: 0.18 %) and the blood (female: 0.07 %, male: 0.07 %) contained relevant amounts of radioactivity.The overall recovery, without the residual carcasses was about 93.1 ± 1.7 % for the female animals and 94.6 ± 1.5 % for the male.
Details on excretion:
After the oral administration of 100 mg/kg of a mixture of N-Tris(2-hydroxyethyl)- C-methylammonium-iodide and the unlabelled test substance to four female rats about 65.5 ± 8.8 % of the radioactive material was recovered in the feces after 72 h. In the four male rats the recovery in the feces was about 57.6 ± 15.3 % of the administered dose. Most of the radioactive material was eliminated in both sexes within the first 48h. The mean total recovery of radioactive material in the urine was 23.5 ± 7.8 % for the female and 33.2 ± 13.9 % for the male rats. Most of the radioactive material was eliminated during the first 24 h.

Metabolite characterisation studies

Metabolites identified:
not measured

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): low bioaccumulation potential based on study resultsMost of the radioactive material was excreted with the feces (about 61 %) within the first three days. 28 % was excreted via urine, most being eliminated within the first 24 hours.